FR2346011A1 - (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders - Google Patents

(4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders

Info

Publication number
FR2346011A1
FR2346011A1 FR7602776A FR7602776A FR2346011A1 FR 2346011 A1 FR2346011 A1 FR 2346011A1 FR 7602776 A FR7602776 A FR 7602776A FR 7602776 A FR7602776 A FR 7602776A FR 2346011 A1 FR2346011 A1 FR 2346011A1
Authority
FR
France
Prior art keywords
dimethylacetanilido
piperazine
phenyl
esp
salts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7602776A
Other languages
French (fr)
Other versions
FR2346011B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Organisation de Synthese Mondiale Orsymonde SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organisation de Synthese Mondiale Orsymonde SA filed Critical Organisation de Synthese Mondiale Orsymonde SA
Priority to FR7602776A priority Critical patent/FR2346011A1/en
Priority to BE2055622A priority patent/BE850709A/en
Publication of FR2346011A1 publication Critical patent/FR2346011A1/en
Application granted granted Critical
Publication of FR2346011B1 publication Critical patent/FR2346011B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

New 1-(2,6-dimethylacetanilido)-4-phenyl piperazine is of formula (I). (I) and/or its non-toxic acid addn. salt(s) are used in therapeutic compsns. contg. a physiologically acceptable excipient. They are used for treating circulatory disorders, partic. of the cardiovascular system.
FR7602776A 1976-02-02 1976-02-02 (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders Granted FR2346011A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR7602776A FR2346011A1 (en) 1976-02-02 1976-02-02 (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders
BE2055622A BE850709A (en) 1976-02-02 1977-01-25 ACETANILIDO-PIPERAZINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7602776A FR2346011A1 (en) 1976-02-02 1976-02-02 (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders

Publications (2)

Publication Number Publication Date
FR2346011A1 true FR2346011A1 (en) 1977-10-28
FR2346011B1 FR2346011B1 (en) 1978-11-03

Family

ID=9168634

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7602776A Granted FR2346011A1 (en) 1976-02-02 1976-02-02 (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders

Country Status (2)

Country Link
BE (1) BE850709A (en)
FR (1) FR2346011A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074768A2 (en) * 1981-09-03 1983-03-23 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Alkanoylanilides
WO2001046200A1 (en) * 1999-12-22 2001-06-28 Astrazeneca Ab Novel piperidine and piperazine derivatives
US6881754B2 (en) 1999-12-17 2005-04-19 Astrazeneca Ab Adamantane derivatives

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757158B1 (en) * 1996-12-18 1999-04-02 Lipha NOVEL 4- (1-PIPERAZINYL) BENZOIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC APPLICATIONS
FR2763334A1 (en) * 1997-05-13 1998-11-20 Lipha Piperazino alkyl anthranilic acid amide

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0074768A2 (en) * 1981-09-03 1983-03-23 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Alkanoylanilides
EP0074768A3 (en) * 1981-09-03 1984-03-07 RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY Alkanoylanilides
US6881754B2 (en) 1999-12-17 2005-04-19 Astrazeneca Ab Adamantane derivatives
US7132457B2 (en) 1999-12-17 2006-11-07 Astrazeneca Ab Adamantane derivatives
US7297818B2 (en) 1999-12-17 2007-11-20 Astrazeneca Ab Adamantane derivatives
WO2001046200A1 (en) * 1999-12-22 2001-06-28 Astrazeneca Ab Novel piperidine and piperazine derivatives
US6969713B2 (en) 1999-12-22 2005-11-29 Astrazeneca Ab Piperidine and piperazine acetamide derivatives
CN1330657C (en) * 1999-12-22 2007-08-08 阿斯特拉曾尼卡有限公司 Novel piperidine and piperazine derivatives

Also Published As

Publication number Publication date
BE850709A (en) 1977-05-16
FR2346011B1 (en) 1978-11-03

Similar Documents

Publication Publication Date Title
IT8419239A0 (en) PROCEDURE AND DEVICE FOR THE NON-INVASIVE DETERMINATION OF THE MINUTE VOLUME OF A HEART.
BG60253B1 (en) HUMAN TISSUE PLASMINOGENIC ACTIVATOR
IE780643L (en) THERAPEUTIC APPLICATION OF d, 1-CARNITINE DERIVITIVES
ES482097A1 (en) Novel acyl-derivatives of carnitine and process for their preparation
JPS5495575A (en) Hydantoin derivative therapeutic medicine
IT7921111A0 (en) DEVICE FOR ARTIFICIAL BREATHING OF PATIENTS.
NZ185279A (en) Medical treatment utilising pseudomonic acid derivative
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
FR2346011A1 (en) (4)-Phenyl-(1)-dimethylacetanilido-piperazine and salts - esp. for treating cardiovascular circulatory disorders
DE3361609D1 (en) New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
BE852460A (en) PHOTOCHEMICAL REACTOR AND IRRADIATION PROCESS
AU2822877A (en) Therapeutic bed for patients
SE7700626L (en) PATIENT CHAIR FOR LTAND TREATMENT
ATA917478A (en) PRODUCTION OF THE NEW N- (5-METHOXYBENZOFURAN-2-YL-CARBONYL) N'-BENZYLP PERAZINE OR ITS ACID ADDITION SALTS
FR2339401A1 (en) Dihydroxyphenacyl piperazines and salts - esp. for treating cardiovascular circulatory disorders
BE871753A (en) NEW THERAPEUTIC USE OF ACETYL-1-CARNITINE FOR THE TREATMENT OF HEART CONDITIONS
NO139784C (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF ANTIMYCOTIC ACTIVE (1-IMIDAZOLYL- (1)) - (1- (4`- (4 "-CHLOROPHENYL) -PHENOXY) -3,3-DIMETHYLBUTAN-2-ON AND ITS SALTS
CA1029305A (en) Infusion solution for the treatment of tachycardiac disturbances of heart rhythm and use thereof
IL48787A0 (en) Pharmaceutical preparations comprising phentolamine,for the treatment of circulatory disorders
ES8307711A1 (en) New alkylene diamine derivatives
NO960347D0 (en) Use of benzydamide in the treatment of pathological conditions caused by TNF
IE42710L (en) Piperazine derivative
DE3876425D1 (en) CONTROLLED ADMINISTRATION OF BLOOD.
SU1169672A1 (en) Method of treatment of disturbances of postural equilibrium
Begalke An introduction to Luther's theology of pastoral care.

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse